Immune suppressive properties of MUC16, along with its expression in ovarian cancer cells and fetal periderm, suggest a role for MUC16 in immune evasion of ovarian cancer cells from the host immune system and in fetal tolerance from maternal immune rejection during early pregnancy [12], [16], [18]. This evidence concerns the gene MUC16 and ovarian carcinoma.